68 An audit of the use of first-line EGFR TKI treatment in NSCLC patients with EGFR activating mutations at the York Teaching Hospitals and Harrogate and District NHS Foundation Trust. (January 2016) - Bhagawati-Prasad, V.; Aspden, E.; Chan, S.; Darby, A.